Universitätsklinikum Köln

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients (2025) Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, et al. Journal article DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms (2025) Schmitt M, Bohnenberger H, Bartsch DK, Wagner DC, Litmeyer AS, Grass A, Rinke A, et al. Journal article AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 (2025) Reimer T, Kuehn T, Mueller V, Ditsch N, Fehm T, Albert US, Bartsch R, et al. Journal article, Review article Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors (2025) Sperber L, von Brandenstein M, Kessler C, Heidenreich J, Storz E, Pfister D, Paffenholz P, et al. Journal article Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study (2025) Ferdinandus S, Rühle A, Lamrani A, Frei C, Kaufmann J, Mäurer M, Wurschi G, et al. Journal article Definition und Klassifikation der pulmonalen Hypertonie (2025) Douschan P, Kaemmerer-Suleiman AS, Egenlauf B, Seyfarth HJ, Zeder K, Mayer L, Wissmüller M, et al. Journal article, Review article Quantification of Exercise-Induced Sarcomeric Damage in R349P Desmin Knock-In Mice: A New Approach in Myofibrillar Myopathy Research (2025) Holtzhausen C, Schultheis D, Berwanger C, Schuld J, Schlötzer-Schrehardt U, Riehl-Nestler M, Batonnet-Pichon S, et al. Journal article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article, Letter